Receptos, Inc. 4
4 · Receptos, Inc. · Filed Jun 16, 2015
Insider Transaction Report
Form 4
Receptos, Inc.RCPT
Torres S. Edward
Director
Transactions
- Sale
Common Stock
2015-06-12$180.33/sh−81,200$14,642,796→ 804,361 total(indirect: See footnote) - Sale
Common Stock
2015-06-15$175.54/sh−88,400$15,517,736→ 715,961 total(indirect: See footnote) - Sale
Common Stock
2015-06-16$182.89/sh−50,400$9,217,656→ 665,561 total(indirect: See footnote)
Holdings
- 7,400
Common Stock
Footnotes (5)
- [F1]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $178.05 to $182.18 per share, inclusive. The reporting person undertakes to provide to Receptos, Inc., any security holder of Receptos, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (1), (3) and (4).
- [F2]These shares are owned directly by Lilly Ventures Fund I, LLC (the "Fund"). Eli Lilly and Company, as sole Managing Member of the Fund, and pursuant to provisions of the LLC Agreement of the Fund, has voting authority with respect to shares owned by the Fund. S. Edward Torres is a non-managing member of the Fund and may be deemed to beneficially own the shares. Mr. Torres disclaims beneficial ownership of the shares held of record by the Fund, except to the extent of his pecuniary interest therein.
- [F3]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $175.00 to $177.49 per share, inclusive.
- [F4]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $175.00 to $188.28 per share, inclusive.
- [F5]Represents time-based restricted stock units which vest 100% on the first anniversary of the 5-28-15 date of grant.